Litigation Details for Apotex Inc. v. Gilead Sciences, Inc. (N.D. Cal. 2018)
✉ Email this page to a colleague
Apotex Inc. v. Gilead Sciences, Inc. (N.D. Cal. 2018)
Docket | ⤷ Try a Trial | Date Filed | 2018-10-23 |
Court | District Court, N.D. California | Date Terminated | 2019-01-30 |
Cause | 28:2201 Declaratory Judgement | Assigned To | Joseph Spero |
Jury Demand | Referred To | ||
Patents | 8,106,183; 9,085,601 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Apotex Inc. v. Gilead Sciences, Inc.
Details for Apotex Inc. v. Gilead Sciences, Inc. (N.D. Cal. 2018)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2019-04-23 | 63 | Order | infringement as to United States Patent Nos. 8,106,183 (“ ’183 Patent”) and 9,085,601 (“ ’601 … 16 Patent”) (collectively, the “patents-in-suit”) in connection with its…inter alia, identify those patents “with respect to which a claim of patent …not infringe any patents listed for the drug in the Orange Book, or that those patents are … 22 a patent or a use of which is claimed by the patent . . . .”). | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |